Cite
APA Citation
Ang, F., Rapattoni, W., Bajaj, H. S., Mancini, G. B. J., Poirier, P., Sharma, A., Wong, N. C., Slee, A., Levin, A., & Mahaffey, K. W. (n.d.). effects of canagliflozin on cardiovascular and kidney outcomes and mortality in primary and secondary cardiovascular prevention: pooled analysis from the CANVAS program and CREDENCE trial. European heart journal, 43, . http://access.bl.uk/ark:/81055/vdc_100168331148.0x000035